Equity Overview
Price & Market Data
Price: $241.9
Daily Change: -$7.21 / 2.98%
Daily Range: $237.0 - $246.0
Market Cap: $17,027,250,176
Daily Volume: 1,386,199
Performance Metrics
1 Week: 0.44%
1 Month: -15.11%
3 Months: -27.46%
6 Months: -27.36%
1 Year: -16.09%
YTD: -14.90%
Company Details
Employees: 5400
Sector: Health technology
Industry: Medical specialties
Country:
Details
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.